Kaštelan S, A. A., Orešković, L., Pelčić, G., Kasun, E. & Hat, K. (2020). Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.. Current Medicinal Chemistry, 27. (8), 1350-1366. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:095194
Kaštelan S, Antunica AG, et al. "Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.." Current Medicinal Chemistry, vol. 27, no. 8, 2020, pp. 1350-1366. https://urn.nsk.hr/urn:nbn:hr:184:095194
Kaštelan S, Antunica AG, LB Orešković, G Pelčić, E. Kasun and K Hat. "Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.." Current Medicinal Chemistry 27, no. 8 (2020): 1350-1366. https://urn.nsk.hr/urn:nbn:hr:184:095194
Kaštelan S, A. A., et al. (2020) 'Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.', Current Medicinal Chemistry, 27(8), pp. 1350-1366. Available at: https://urn.nsk.hr/urn:nbn:hr:184:095194 (Accessed 20 November 2024)
Kaštelan S AA, Orešković L, Pelčić G, Kasun E, Hat K. Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.. Current Medicinal Chemistry [Internet]. 2020 [cited 2024 November 20];27(8):1350-1366. Available at: https://urn.nsk.hr/urn:nbn:hr:184:095194
A. A. Kaštelan S, L. Orešković, G. Pelčić, E. Kasun and K. Hat, "Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.", Current Medicinal Chemistry, vol. 27, no. 8, pp. 1350-1366, 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:095194. [Accessed: 20 November 2024]